StockWatch
·

Scoda Tubes Ltd Q2 FY27 Results

SCODATUBESQ2 FY27 Results
Filing
Result:Poor· Market: Crashed#Margin squeeze

Beat/Miss: Miss · Outlook: Cautiously Optimistic · Guidance: Cut

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue148.9519.8%2.5%
Total Income150.9419.8%1.4%
Expenditure144.9021.8%11.3%
PBT6.0313.8%67.9%
Net Profit4.798.9%65.8%
OPM10.60%2.25pp4.78pp
NPM3.17%1.00pp6.21pp
EPS0.809.1%66.9%
View full financials

Manufacturing core metric (adjusted PAT/EBITDA margin) deteriorated sharply YoY with OPM down ~480bps and PAT -66% despite flat-to-modest revenue growth, and H1 run-rate is missing management's own FY27 growth/margin guidance.

SCODA TUBES · Q2 FY27 · THE VERDICT

Flat Revenue, Margin Collapse, Guidance Cut — Execution Risk Now Critical

Scoda guided 25% FY27 revenue growth and 14–15% EBITDA margins. Q2 delivered flat revenue (+2.5%), margins crushed to 10.6% (479 bps below guidance), and PAT down 65.7%. Management has now hedged guidance, withdrawn margin targets, and delayed the welded ramp that was supposed to drive recovery.

16 Nov 2026 · 6 min read
Q2 Revenue

₹148.9 Cr

+2.5% YoY

Q2 PAT

₹4.8 Cr

−65.7% YoY

EBITDA margin

10.6%

−479 bps vs FY26 | −479 bps vs guidance

Order book

₹185 Cr

4–5 month execution window

On paper, Scoda's Q2 delivered stable revenue (+2.5% YoY) and a comforting order book of ₹185 crore. But beneath the headline sits the real quarter: PAT down nearly 66%, EBITDA margins at their lowest in recent memory, and management's explicit abandonment of margin targets. This is not a soft quarter. This is a warning.

Guidance vs. reality: where the credibility cracked

In prior calls, Scoda promised 25% FY27 revenue growth and 14–15% EBITDA margins. Six months in, the company is delivering neither. Q2 revenue grew just 2.5% YoY. H1 (two quarters in) reached 12.6% YoY growth. To hit even the newly hedged floor of 20% FY27 growth, Scoda needs H2 to grow 30% or faster—a leap management has not articulated a credible path to achieve.

Management claims vs. what the numbers support

Revenue remained largely flat YoY

₹148.9 Cr, +2.5% YoY vs ₹145.3 Cr Q2 FY26

Supported

Reaffirm 20–25% FY27 revenue growth confidence

Q2 +2.5%, H1 +12.6%; H2 needs 30%+ to hit 20% floor

Overstated

EBITDA margin 10.6% reflects power/fuel cost pressure

10.6% vs 15.38% Q2 FY26; vs 14–15% prior guidance

Supported (but magnitude was hidden)

Order book ₹185 Cr provides visibility

All seamless; no welded orders despite welded ramp starting Q4

Contradicted

Seamless capacity utilization targeting ~70%

Management refused to disclose actual utilization

Unverified

What changed on this call

  • EBITDA margin guidance withdrawn (was 14–15%, now refused)

  • Revenue guidance narrowed and hedged (was 25%, now 20–25%)

  • Welded project delayed 2–3 months; trial now Q4 FY27, commercial Jan 2027

  • Net debt doubled to ₹100 Cr from ₹40 Cr; peak expected ₹250 Cr

  • PAT margin collapsed to 3.2% from 9.5% YoY

Every major metric moved in the wrong direction. The withdrawal of margin guidance is the tell—when management removes a target, it signals internal conviction has cracked. Scoda no longer believes in a near-term margin recovery path, and refused to quantify one under analyst pressure.

The bull case and the bear case

The honest read: Scoda has a defensible long-term story, but near-term credibility is shot. Management has explicitly wavered on margin recovery and hedged on growth—that matters more than the welded thesis. For a holder today, the binary is unforgiving: either H2 delivers 30%+ growth AND management re-guides on margins, or the stock reprices lower. The market is clearly betting the latter.

The bull-bear ledger

  • ₹185 Cr order book; 4–5 month execution horizon provides near-term revenue certainty

  • Welded and new verticals (data centers, HVAC, marine) address structural market shifts

  • 4.99 MW solar; cost tailwind for welded ops starting Jan 2027

  • RINA Marine audit complete; European marine orders pipeline opens

  • Revenue flat despite ₹185 Cr order book—execution drag or inventory buildup?

  • EBITDA margin guidance withdrawn—management sees no clear path to recovery

  • Welded delayed 2–3 months; brownfield capex also at execution risk

  • Domestic segment weak (oil/gas −12%); power tenders timing uncertain

  • Industry capacity additions 60–70K tons; pricing power constrained

  • Net debt ₹100 Cr, peak ₹250 Cr; declining profit hampers repayment

Risks, ranked by how much they should concern a holder

Execution risk on welded capacity ramp

HIGH

Welded project already delayed 2–3 months (civil/labour disruptions). Trial production Q4 FY27, commercial launch Jan 2027. Brownfield 8,000 MT capex also at risk. If welded misses, FY27 revenue growth target is impossible.

Margin recovery path opaque

HIGH

Management explicitly withdrew EBITDA margin targets (was 14–15%). Under analyst pressure, refused to quantify recovery. Power costs still high; competition limits pass-through. No credible path to prior guidance.

Domestic segment weakness

HIGH

Oil & gas sector running low; domestic revenue down 12% YoY. Power sector strong but dependent on BHEL/NTPC tender awards—timing uncertain. 63% of revenue is domestic; weakness cascades.

Competitive capacity oversupply

HIGH

Industry added 60–70K tons new seamless capacity. All from private players. Pricing power constrained; Scoda's 20K MT capacity now smaller relative to industry. Revenue growth may require volume gains at margin sacrifice.

Rising debt amid PAT collapse

MEDIUM

Net debt ₹100 Cr (vs ₹40 Cr prior); peak ₹250 Cr expected. PAT down 65.7% YoY; profit pool shrinking while debt rises. Debt repayment hinges on growth realization—if that slips, leverage becomes dangerous.

Working capital deterioration

MEDIUM

Inventory buildup (production elevated for demand that didn't materialize); cash conversion slowed due to competitive pressures. ~70% of cash stuck in working capital. Normalization expected H2 but if demand remains soft, WC drag persists.

How the street is positioned

The stock sits at ₹102.34, trading 55% below its all-time high of ₹230.85. Over the past 52 weeks, it has range-bound between ₹101.5 and ₹181.48—and it is now near the lows. Trading below its 20-day, 50-day, and 200-day moving averages (at ₹108.68, ₹119.9, and ₹133.45 respectively), the price action is decisively bearish. RSI at 33.6 suggests neutral momentum (not oversold enough yet to trigger a technical bounce).

Volume is increasing on the way down—a distribution signal. Institutions are selling. FII ownership is steady at 8.58% (up 20 bps from Q1), but DII ownership has collapsed to 0.44% from 3.58% in Q1—a sharp 314 bps exit by domestic institutions. This is a caution signal: the DII (often viewed as informed sellers) is trimming.

Bulk dealing data adds color. On May 27, HUTOXY KERSI BHADHA sold 3.08 lakh shares at ₹127.77 per share. On May 8, MNCL CAPITAL COMPOUNDER FUND sold 5 lakh shares at ₹157.56. Both transactions occurred at prices near the 52-week highs—informed sellers, likely sophisticated investors, reducing exposure before the weakness became apparent.

The combined picture is clear: the stock has re-rated lower in line with a credibility loss. The 55% drawdown from ATH is not overdone given the fundamentals—execution risk is real, margins are under pressure, and management has lost conviction. For a speculative entry (betting on H2 execution and margin recovery), the price may offer opportunity. But for a holder, the technical picture and institutional flow suggest the re-rating may not be finished.

What to watch next—the resolve

  • 1 · H2 FY27 revenue growth trajectory

    The make-or-break metric. Scoda needs 30%+ H2 growth to hit even the 20% FY floor. If H2 revenue growth lands below 15%, the bear case wins and further downside is likely. Track Q3 results (expected Jan 2027) as the first read.

  • 2 · Welded trial production and commercial ramp success

    Trial production expected Q4 FY27; commercial launch Jan 2027. Any further delays or production issues invalidate the long-term thesis. Listen for updates in the Q3 call (Jan 2027) on trial progress and commercial readiness.

  • 3 · Domestic demand stabilization and BHEL/NTPC tender awards

    Oil & gas is weak; power is the lone bright spot. BHEL and NTPC tender awards will determine whether domestic revenue can recover from −12% YoY. If these awards are delayed or won by competitors, domestic recovery is derailed and FY27 growth is at risk.

  • 4 · Management commentary on EBITDA margin recovery

    The next earnings call (Q3 FY27, expected Jan 2027) will be the test. Does management re-guide on margins (even cautiously) or continue to hedge? A re-guidance would signal returning conviction; further hedging would validate the bear case.

Scoda Tubes has a long-term thesis—welded capacity ramp, new verticals, cost tailwinds—but near-term credibility is in tatters. Flat Q2 revenue, margin collapse, guidance withdrawal, and execution delays have shattered management's narrative. The market's repricing (55% from ATH) reflects justified skepticism.

This is not a valuation story anymore. It's an execution story. For a holder, the binary is unforgiving: either H2 delivers a growth rate above 15% AND management re-guides on margins, or the stock reprices lower. The street has clearly chosen to bet against near-term execution. Until proven wrong, that read likely holds.

The single metric to track: H2 revenue growth rate. Below 15%, the bear case is validated. Above 20%, credibility begins to return. Anything in between is a coin flip with execution risk tilted to the downside.

Informational and educational content only. Not investment advice.